This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Glutamate Receptor (GRIN1), N-His and C-strep
Product Overview
BioVenic's Recombinant Equine Glutamate Receptor (GRIN1), N-His and C-strep is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 45 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Horse GRIN1 (Glutamate Ionotropic Receptor NMDA Type Subunit 1) encodes the essential glycine-binding subunit of the N-methyl-D-aspartate (NMDA) receptor. Unlike other subunits, GRIN1 is mandatory for the formation of functional NMDA receptor complexes. As a ligand-gated ion channel, it mediates calcium influx critical for long-term potentiation, synaptic plasticity, and memory formation. In equine research, it is studied for its role in neurodevelopmental processes and the pathophysiology of neurological disorders and chronic pain signaling.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.